The observations that IL10RB-DT activation suppresses IFN-γ signaling in cancer cells and decreases CD8+ T cell activation led us to hypothesize that IL10RB-DT might regulate IFN-γ and antigen presentation and processing pathways. The gene discussed is CD8A; the disease is cancer.